NHL Player Alexis LaFreniere teams up with Kraft Peanut Butter to launch fund for life-saving epinephrine
TORONTO, Nov. 22, 2021 /CNW/ - According to Food Allergy Canada, research shows that less than 50 percent of individuals with food allergies have access to epinephrine auto-injector medication. One of the barriers to this access may be due to cost. At an average cost of $120, this cost quickly adds up. As part of Kraft Peanut Butter’s ongoing mission to support the food allergy community, the brand believes that all Canadians should have equal access to life-saving medication like epinephrine – and it should not cost more than a jar of peanut butter. That’s why it’s launching Protection for Peanuts, a fund to help offset the cost of life-saving epinephrine auto-injectors and teamed up with Alexis LaFreniere, an NHL player with a life-threatening peanut allergy to help spread awareness.
"I've relied on my allergy medication to keep me safe my whole life, many may not know this, but you need more than one auto-injector - and they expire every year – so I always make sure I have several on me at all times. It's truly a lifeline for me and millions of Canadians," said Alex Lafrenière. "I'm proud to be a part of the campaign this year, and as somebody who lives with a peanut allergy, I am grateful that Kraft Peanut Butter is supporting the food allergy community with such an important cause."
It’s estimated that more than 3 million Canadians are impacted by food allergy and potentially at-risk of a severe allergic reaction requiring life-saving medication. When it comes to top food allergens in Canada, peanuts are high on the list. The only treatment for anaphylaxis is epinephrine auto-injectors, which cost nearly 25 times more than what it’s protecting against, such as peanut butter. While coverage varies from province-to-province, out-of-pocket costs rely heavily on income level and private insurance and many Canadians are on the hook for their life-saving medication every year.
"We are passionate about nourishing Canadians and as the market leader in the peanut butter category, are deeply connected to the food allergy cause." says Daniel Gotlib, Associate Director, Brand Building & Innovation, Kraft Heinz Company. "Through Protection for Peanuts, the hope is to shed light on allergy medication coverage gaps in Canada and help offset the costs of life-saving medication to drive meaningful change."
Starting November 22nd, Canadians with less than 100% coverage can visit Kraft Peanut Butter's Protection For Peanuts Fund at www.protectionforpeanuts.com and submit their receipts to be reimbursed for their out-of-pocket expenses, making their allergy medication cost no more than a jar of peanut butter.
All Canadians can join the movement and contribute to lasting change for those with food allergies by using #ProtectionforPeanuts on social media to help raise awareness and drive conversation around the need for increased access to life-saving epinephrine auto-injectors.
About Kraft Heinz Canada
Kraft Heinz Canada is the country's largest food and beverage company and is a subsidiary of Kraft Heinz (NASDAQ: KHC). Kraft Heinz Canada provides high quality, great taste and nutrition for all eating occasions whether at home, in restaurants or on the go. Kraft Heinz Canada products are found in more than 97 per cent of Canadian households. The Company's iconic brands include Kraft Peanut Butter, KD, Classico. Kraft Heinz Canada is dedicated to the sustainable health of our people, our planet and our Company. For more information, please visit www.kraftheinzcompany.com.
SOURCE Kraft Heinz Canada
Emily Kett, [email protected]
Share this article